ArticleArchives of endocrinology and metabolism
Correction: Peptide receptor radionuclide therapy (PRRT) in radioiodine-refractory thyroid cancer: A case report of significant response to lu177 DOTA-TATE treatment.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.